Media Contact
Larissa Doucette
847-391-4405
help@nabp.pharmacy
NABP will soon be accepting applications for .pharmacy domain names from trademark holders who are registered in the Internet Corporation for Assigned Names and Numbers (ICANN) Trademark Clearinghouse (TMCH). The sunrise application period, which begins December 19, 2014, precedes the Sunrise TMCH Registration Period, which will be from January 15 to March 16, 2015. NABP launched the .pharmacy Top-Level Domain (TLD) to provide consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources.
During the sunrise application and registration phase, eligible trademark holders who have logged their brand names in the ICANN TMCH may apply to NABP for approval to register .pharmacy domain names that exactly match their trademark names in the TMCH. Once approved, these organizations will be able to register the domain with an approved registrar. The Sunrise Period will begin immediately following a special members-only registration period in for NABP’s member boards of pharmacy.
Following the Sunrise Period, registration for .pharmacy domain names will be open to pharmacy websites that are accredited through the NABP Verified Internet Pharmacy Practice Sites® (VIPPS®) and Veterinary-Verified Internet Pharmacy Practice SitesCM (Vet-VIPPS®) programs, as well as for pharmacy websites that have received approval through the NABP e-Advertiser ApprovalCM Program. Applications from other dispensing pharmacies will be accepted beginning in mid-2015. General availability will begin in June 2015, at which time all entities providing pharmacy-related products, services, or information that meet .pharmacy eligibility standards will be able to apply to register for the domain.
The .pharmacy domain application will be available at www.dotpharmacy.net beginning December 19, 2014. Additional information about the .Pharmacy TLD Program, as well as NABP’s most recent research on rogue online drug sellers is also available on the site. The full press release is also available on the .pharmacy website.